WEST LAFAYETTE, Ind., April 8, 2011 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT), a biopharmaceutical company developing targeted therapies for the treatment of cancer and inflammatory diseases, announced today that Mike Sherman, chief financial officer of Endocyte, will present at the upcoming BioCentury Future Leaders in the Biotech Industry Conference on Friday, April 15th, 2011, at 1:30 p.m. EDT at the Millennium Broadway Hotel in New York City.
